Tony Chetty

, MD, FRCPC, MSc

Associate Professor
Pathology and Molecular Medicine

Division: Anatomical Pathology

Discipline Director, Clinical Chemistry and Immunology (HRLMP)

St. Joseph's Healthcare
L402-3, St. Luke's Wing
Hamilton, Ontario
905-522-1155 ext. 34366
chetty@hhsc.ca

Education and Professional Standing

FRCPC, Medical Biochemistry
MSc, Health Research Methodology

---

Interests

Research Focus

Dr. Chetty's research interests include Metabolic Syndrome, Diabetes prevention, lipid metabolism and obesity.

Clinical Focus

Dr. Chetty’s clinical focus includes obesity, diabetes and lipid disorders.  He runs three clinics a week at the Hamilton General Hospital and he is presently the Medical Director of the Bariatric Medical Clinic. 

Academic Interests

Dr. Chetty is involved in teaching Undergraduate Medical Students and Residents for Medical Biochemistry. 

---

Selected Publications

• Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance.  Acta Diabetol. 2005 Apr; 42 Suppl 1:S3-8.
• Sharma AM, Chetty VT. Weight cycling and hypertension.  Curr Hypertens Rep. 2005 Feb; 7 (1): 9-10.
• Chetty VT, Sharma AM: Can PPAR gamma agonist have a role in the management of obesity-related hypertension invited review – Vascular Pharmacology; 2006. (45) 46-53.
• Chetty VT, Almulla A, Odueyungbo A, Thabane L. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c(HBA1c) levels in Type I diabetic patients: a systematic review.  Diab Res Clin Pract. 2008; 81 (1):79-87. 
• A.C. Don-Wauchope, V.T Chetty Laboratory defined critical value limits: How do hospital physicians perceive laboratory based critical values? Clinical Biochemistry 42(9): 766-70.
• Adel Elsheriff, Chetty VT Invited review “Novel Therapies for type 2 diabetes” Canadian Journal of Diagnostics Feb 2010.